Trademark Details For JAKAFI XR (Serial Number 99038809)

  •  Home
  •  Print
JAKAFI XR
1
8
3
0
Basic Information
Serial Number  United States - USPTO 99038809
Registration Number -
Mark
JAKAFI XR
Filing Date Feb-12-2025
Status
Pending  
FIRST EXTENS.. (730)
FIRST EXTENSION - GRANTED
Attorney Name
TTAB
0


  • INCYTE HOLDINGS CORPORATION

  • Mark Literal Elements:

005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active

044Medical, beauty and agricultural

U.S Class(es): 100, 101

Class Status: Active





Correspondences

NameMakiko Coffland CHRISTENSEN O'CONNOR JOHNSON KINDNESS
Address1201 THIRD AVENUE, SUITE 3600 SEATTLE, WA 98101 United States

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Feb-12-2025NEW APPLICATION ENTERED   NWAPI
Feb-12-2025APPLICATION FILING RECEIPT MAILED   MAFRO
Jul-11-2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jul-21-2025ASSIGNED TO EXAMINER   DOCKD
Jul-22-2025EXAMINERS AMENDMENT -WRITTEN   CNEAR
Jul-22-2025EXAMINERS AMENDMENT E-MAILED   GNEAF
Jul-22-2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED   GNENO
Jul-22-2025EXAMINER'S AMENDMENT ENTERED   XAECI
Jul-22-2025APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Aug-20-2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Aug-26-2025PUBLISHED FOR OPPOSITION   PUBOA
Aug-26-2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Oct-21-2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Dec-09-2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Dec-09-2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Dec-09-2025TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Dec-09-2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS   EWAFI
Mar-31-2026SOU TEAS EXTENSION RECEIVED   EEXTI
Mar-31-2026SOU EXTENSION 1 FILED   EXT1S
Mar-31-2026SOU EXTENSION 1 GRANTED   EX1GS
Apr-01-2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE